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Signal transduction cascades, such as Hedgehog (Hh) signaling, are potentially important targets for new drugs. A new
study in this issue of Cell Metabolism (Suh et al., 2006) identifies hedgehog signaling in the formation of the Drosophila
fly body and in mammalian adipogenesis.The desire to control human adiposity
has spurred a proliferation of studies
on adipogenesis, and new pathways are
continually being added to our map of
this process. Much of what we know
has come from studies in established
pre-adipocytic cell lines such as 3T3-L1
and 3T3-F442A, which can be induced
to differentiate by exposing them to pro-
adipogenic cocktails including combina-
tions of insulin, cAMP, glucocorticoids,
and thyroid hormone. Other progenitor
cell types such as ES cells, embryonic fi-
broblasts, and multipotent mesenchymal
cell lines like C3H10t1/2 have also been
used. Since the ultimate goal is to under-
stand fat cell formation in vivo, it is fortu-
nate that many, if not most, of the key
findings derived from cell culture-based
studies have held up reasonably well in
transgenic and knockout mouse models.
Because mice are not always easy to
work with, and have their own limitations,
a number of groups have turned to inver-
tebrate systems, such as C. elegans and
Drosophila, as models of adipogenesis.
A new report from Suh et al. (2006) identi-
fies the hedgehog pathway in fly fat body
formation and goes on to show a similar
role in mammalian adipogenesis. More-
over, they show that Hh signals appear
to divert progenitor cells away from fat
and toward bone formation.
Are flies and worms suitable models
for mammalian fat cell biology? The an-
swer is ‘‘maybe,’’ or perhaps more accu-
rately, ‘‘it depends.’’ Certainly these ani-
mals have cells that can store calories
as esterified lipid and then release them
as fatty acids, a primary function of fat
cells. Much of the enzymatic machinery
that makes this possible is conserved
through evolution, and biochemical and
expression studies of these genes and
proteins in lower organisms would seem
to be fair game. Adipogenesis per se is a
little trickier, in that there is debate over
whether these lipid-storing cells can be
considered truly orthologous to verte-
brate adipocytes. In Drosophila, for ex-
ample, the fat body is also the site of
detoxification and sugar biosynthesis, aCELL METABOLISM 3, 1–7, JANUARY 2006 ª2featuremore reminiscent of hepatocytes.
Cells of the fat body also participate in
the immune system of the fly. In the
end, however, the only thing that really
matters is whether findings from these
models can be shown to be relevant in
more traditional systems. Despite the
conservation of many developmental
pathways, this hasn’t been easy to ac-
complish. For example, serpent (srp) is
one of three GATA-like factors in Dro-
sophila and has been shown to play an
important role in promoting fat body de-
velopment in flies (Hayes et al., 2001). In
mammalian systems, GATA factors are
also involved in adipogenesis, but they
are antiadipogenic (Tong et al., 2000,
2005). Thus, one’s opinion of the utility of
the invertebrate model of adipogenesis
depends upon whether you think that
the identification of GATA as a player in
this process represents an important ad-
vance, or whether you believe that the
opposite actions of GATA in mice and
flies calls the whole enterprise into ques-
tion. Similarly, Wnt signaling in mammals
has strong antiadipogenic actions (Ross
et al., 2000), while the actions of the or-
thologous wingless (wg) gene in flies are
antiadipogenic in the dorsolateral fat
body but proadipogenic in the ventral
fat body (Riechmann et al., 1998).
Hedgehog signaling is another highly
conserved pathway (Figure 1). In flies,
hedgehog has profound effects on em-
bryonic patterning, a role generally con-
served in vertebrates. In mammals there
are three hedgehog orthologs, including
sonic hedgehog (Shh), Indian hedgehog
(Ihh), and Desert hedgehog (Dhh). These
secreted molecules have important de-
velopmental effects on multiple cell
types, and various labs have attempted
to look at the effect of hedgehog signal-
ing on fat cell differentiation. Treatment
of C3H10t1/2 cells with BMP-2 can pro-
mote osteogenesis and adipogenesis,
and two groups have shown that Shh
blocks adipogenesis in these cells while
enhancing the osteogenic response to
BMP-2 (Spinella-Jaegle et al., 2001;
Zehentner et al., 2000). The suggestion006 ELSEVIER INC.was thusmade thatShhmighthavesome-
thing to do with mammalian adipogene-
sis, but the idea was not pursued further.
Into the breach comes the paper by
Suh et al. in this issue ofCell Metabolism.
These authors, strong proponents of
invertebrate modeling of mammalian
adipocyte biology, pulled the hedgehog
receptor smoothened (smo) out of an en-
hancer trap experiment designed to find
elements driving Drosophila fat body
gene expression. Further analysis in the
fly showed that activating the hedgehog
pathway in a variety of ways (by overex-
pressing either Hh itself, its receptor
Smo, or its downstream transcriptional
effector, Ci) reduced lipid accumulation
and tissue-specific gene expression in
the fat body, and that a dominant nega-
tive Ci had the opposite effects. They
next turned to mammalian fat cells and
showed that components of the hedge-
hog signaling system are expressed in
3T3-L1 cells, with a pattern suggesting
that expression of pro-hedgehog mole-
cules declines during adipogenesis while
molecules predicted to oppose hedge-
hog action rise. Direct exposure of Shh
to 3T3-L1 cells inhibited adipogenesis,
as did retroviral introduction of an acti-
vated form of the Shh receptor. Con-
versely, inhibition of hedgehog signaling
by pharmacological blockade or by ad-
dition of a dominant-negative Gli (the
mammalian ortholog of Ci) enhanced fat
cell development. In C3H10t1/2 cells,
Shh pushed cells toward an osteogenic
fate at the expense of adipogenesis, as
shown previously. Hedgehog signaling
has several distal effectors, and the au-
thors identified GATA as a mediator of
the Shh effect on adipogenesis. This
finding is particularly gratifying in that it
connects the hedgehog story to a factor
already known to be antiadipogenic.
There are several features that make
this paper interesting. First, it identifies
hedgehog as a player in adipogenesis
from an unbiased screen, suggesting the
general importance of the pathway. Sec-
ond, it shows that hedgehog behaves
similarly upon the biology of fatty tissues1
P R E V I E W SFigure 1. Functional relationship between Hh signaling in fat body development in Drosophila (left) and adipo-
genesis in mammalian cells (right)
In flies, Hh binds to Ptc, thus releasing Smo from inhibition. A series of intracellular events results in activation of
theCi transcription factor, which inhibits fat body development via an unclearmechanism. Some possibilities are
shown, including inhibition of theproadipogenicGATA-like factorSerpent. Alternatively, Ci could activate ananti-
adipogenic GATA-like molecule (if one exists), which would make the system analogous to mammalian cells. In
mammals, Shh activates the Gli family of transcription factors, which either directly or indirectly activate antiadi-
pogenicGATA factors.GATA2and3havebeen shown to repress thePPARg2promoter and to inhibit the function
of C/EBP proteins through a direct interaction. In both flies and mice, other pathways remain possible as well.in flies andmammalian cells, lending cre-
dence to the idea that invertebrates can
be useful models for adipogenesis. Third,
it suggests that drugs designed tomanip-
ulate hedgehog signalingmight have util-
ity in human metabolic diseases of al-
tered adiposity, such as obesity and
lipodystrophy.
This last point bears closer analysis.
Could Shh agonists be used to treat
obesity? Though seemingly obvious—
anything that causes fewer fat cells
should reduce weight gain and its ad-
verse sequelae—this is, however, not
necessarily so. Fat cells provide a sink
for calories, buffering excess nutrients
in a ‘‘safe’’ environment. As long as
food intake exceeds energy expenditure
(an all-too-common scenario in our soci-
ety), those extra calories have to go
somewhere. If adipogenesis is inhibited,
they end up as ectopic lipid deposits in
places like muscle and liver, which may
itself cause significant insulin resistance.
Certainly fatty liver is a well-known pre-
cursor to cirrhosis. The ‘‘problem’’ in
obesity is energy balance that is out-of-
whack, and not a surfeit of adipocytes
per se.2Furthermore, activation of hedgehog
signaling might have effects on other tis-
sues that could impact upon bodyweight
(even leaving aside the expected pro-
oncogenic effects). For example, mice
with a constitutively active hedgehog
pathway are heavier than littermates,
not lighter (Makino et al., 2001). The same
effect has been seen with an injectable
hedgehog agonist (Martin et al., 2002),
and anti-hedgehog therapy protects
against diet-induced obesity (Buhman
et al., 2004). The reasons for this are
unclear but may reflect general changes
in cell proliferation (Makino et al., 2001),
altered lipid transport in the intestine
(Buhman et al., 2004), or the positive
effect of Shh on insulin transcription in
pancreatic b cells (Thomas et al., 2000).
Regardless of the mechanism, these re-
sults are obviously discordant with the
notion of using systemic Shh therapy to
treat obesity. One interesting possibility
is the use of hedgehog agonists for oste-
oporosis. Like C3H10t1/2 cells, marrow
stromal cells in vivo canbe induced to be-
come adipocytes or osteocytes; during
aging, the former predominates over the
latter. Drugs that mimic the actions ofShh might tip the balance back to bone
formation.
Regardless of the therapeutic implica-
tions, the paper bySuh et al. will stimulate
the adipogenesis community to incorpo-
rate hedgehog signaling into their think-
ing. There are still a number of openques-
tions that need answers. For example,
can the in vitro findings be extended to
whole animals? What is the source of the
Shh, and what effectors other than GATA
mightbeinvolved in transducingthedown-
streamsignal? Flies andworms are partic-
ularly useful organisms for identifying such
epistatic genes. Finally, can Shh signal in
mature adipocytes, and, if so, what are the
metabolic consequences? Suh and col-
leagues have put hedgehog back on the
adipogenesis map. How big a piece of the
map it occupies remains to be seen.
Evan D. Rosen1
1Division of Endocrinology, Beth Israel
Deaconess Medical Center, Boston,
Massachusetts 02115
Selected reading
Buhman, K.K., Wang, L.C., Tang, Y., Swietlicki,
E.A., Kennedy, S., Xie, Y., Liu, Z.Y., Burkly, L.C.,
Levin, M.S., Rubin, D.C., and Davidson, N.O.
(2004). J. Nutr. 134, 2979–2984.
Hayes, S.A., Miller, J.M., and Hoshizaki, D.K.
(2001). Development 128, 1193–1200.
Makino, S., Masuya, H., Ishijima, J., Yada, Y., and
Shiroishi, T. (2001). Dev. Biol. 239, 95–106.
Martin, P.L., Lane, J., Pouliot, L., Gains, M., Stej-
skal, R., Smith, S.Y., Galdes, A., and Green, J.
(2002). Drug Dev. Res. 57, 107–114.
Riechmann, V., Rehorn, K.P., Reuter, R., and
Leptin, M. (1998). Development 125, 713–723.
Ross, S.E., Hemati, N., Longo, K.A., Bennett,
C.N., Lucas, P.C., Erickson, R.L., and MacDou-
gald, O.A. (2000). Science 289, 950–953.
Spinella-Jaegle, S., Rawadi, G., Kawai, S., Gal-
lea, S., Faucheu, C., Mollat, P., Courtois, B., Ber-
gaud, B., Ramez, V., Blanchet, A.M., et al. (2001).
J. Cell Sci. 114, 2085–2094.
Suh, J.M.,Gao, X.,McKay, J.,McKay,R., Salo, Z.,
and Graff, J.M. (2006). Cell Metab. 3, this issue,
25–34.
Thomas, M.K., Rastalsky, N., Lee, J.H., and Hab-
ener, J.F. (2000). Diabetes 49, 2039–2047.
Tong,Q.,Dalgin,G., Xu,H., Ting,C.N., Leiden, J.M.,
andHotamisligil,G.S. (2000).Science290, 134–138.
Tong, Q., Tsai, J., Tan, G., Dalgin, G., and Hota-
misligil, G.S. (2005). Mol. Cell. Biol. 25, 706–715.
Zehentner, B.K., Leser, U., and Burtscher, H.
(2000). DNA Cell Biol. 19, 275–281.
DOI 10.1016/j.cmet.2005.12.002CELL METABOLISM : JANUARY 2006
